Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multimodal platform for assessing drug distribution and response in clinical trials.
Lopez BGC, Kohale IN, Du Z, Korsunsky I, Abdelmoula WM, Dai Y, Stopka SA, Gaglia G, Randall EC, Regan MS, Basu SS, Clark AR, Marin BM, Mladek AC, Burgenske DM, Agar JN, Supko JG, Grossman SA, Nabors LB, Raychaudhuri S, Ligon KL, Wen PY, Alexander B, Lee EQ, Santagata S, Sarkaria J, White FM, Agar NYR. Lopez BGC, et al. Among authors: supko jg. Neuro Oncol. 2022 Jan 5;24(1):64-77. doi: 10.1093/neuonc/noab197. Neuro Oncol. 2022. PMID: 34383057 Free PMC article.
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.
Grossman SA, Alavi JB, Supko JG, Carson KA, Priet R, Dorr FA, Grundy JS, Holmlund JT. Grossman SA, et al. Among authors: supko jg. Neuro Oncol. 2005 Jan;7(1):32-40. doi: 10.1215/S1152851703000353. Neuro Oncol. 2005. PMID: 15701280 Free PMC article. Clinical Trial.
Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.
Grossman SA, Olson J, Batchelor T, Peereboom D, Lesser G, Desideri S, Ye X, Hammour T, Supko JG; New Approaches to Brain Tumor Therapy CNS Consortium. Grossman SA, et al. Among authors: supko jg. Neuro Oncol. 2008 Apr;10(2):190-8. doi: 10.1215/15228517-2007-055. Epub 2008 Feb 20. Neuro Oncol. 2008. PMID: 18287342 Free PMC article. Clinical Trial.
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
Grossman SA, Carson KA, Phuphanich S, Batchelor T, Peereboom D, Nabors LB, Lesser G, Hausheer F, Supko JG; New Approaches to Brain Tumor Therapy CNS Consortium. Grossman SA, et al. Among authors: supko jg. Neuro Oncol. 2008 Aug;10(4):608-16. doi: 10.1215/15228517-2008-030. Epub 2008 Jun 24. Neuro Oncol. 2008. PMID: 18577560 Free PMC article. Clinical Trial.
Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study.
Blakeley JO, Olson J, Grossman SA, He X, Weingart J, Supko JG; New Approaches to Brain Tumor Therapy (NABTT) Consortium. Blakeley JO, et al. Among authors: supko jg. J Neurooncol. 2009 Jan;91(1):51-8. doi: 10.1007/s11060-008-9678-2. Epub 2008 Sep 12. J Neurooncol. 2009. PMID: 18787762 Free PMC article. Clinical Trial.
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.
Phuphanich S, Supko JG, Carson KA, Grossman SA, Burt Nabors L, Mikkelsen T, Lesser G, Rosenfeld S, Desideri S, Olson JJ. Phuphanich S, et al. Among authors: supko jg. J Neurooncol. 2010 Oct;100(1):95-103. doi: 10.1007/s11060-010-0143-7. Epub 2010 Mar 8. J Neurooncol. 2010. PMID: 20213332 Free PMC article. Clinical Trial.
128 results